Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.
作者信息
Verbeeck R K, Wallace S M, Loewen G R
出版信息
Br J Clin Pharmacol. 1984 Jun;17(6):783-4. doi: 10.1111/j.1365-2125.1984.tb02421.x.
Abstract
摘要
相似文献
1
Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.老年人酮洛芬消除率降低不一定是由于葡萄糖醛酸化受损。
Br J Clin Pharmacol. 1984 Jun;17(6):783-4. doi: 10.1111/j.1365-2125.1984.tb02421.x.
2
3
Effects of probenecid on ketoprofen kinetics.
Clin Pharmacol Ther. 1982 Jun;31(6):705-12. doi: 10.1038/clpt.1982.99.
4
Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.
J Pharmacol Exp Ther. 1987 Feb;240(2):637-41.
5
6
Pharmacokinetics of ketoprofen in the elderly.酮洛芬在老年人中的药代动力学。
Br J Clin Pharmacol. 1983 Jul;16(1):65-70. doi: 10.1111/j.1365-2125.1983.tb02145.x.
7
A renal mechanism for the clofibric acid-probenecid interaction.
J Pharmacol Exp Ther. 1983 Dec;227(3):739-42.
8
A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
Int J Clin Pharmacol Ther Toxicol. 1984 Mar;22(3):131-3.
9
Pharmacokinetic profile of controlled release ketoprofen in elderly patients.老年患者中缓释酮洛芬的药代动力学特征。
Br J Clin Pharmacol. 1985 Dec;20(6):567-73. doi: 10.1111/j.1365-2125.1985.tb05113.x.
10
Pharmacokinetics of ketoprofen in patients with chronic renal failure.酮洛芬在慢性肾衰竭患者中的药代动力学。
Scand J Rheumatol. 1981;10(3):189-92. doi: 10.3109/03009748109095297.
引用本文的文献
1
Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.非甾体抗炎药（NSAIDs）的药物不良相互作用。识别、管理与避免。
Drug Saf. 1993 Feb;8(2):99-127. doi: 10.2165/00002018-199308020-00002.
2
Nonsteroidal anti-inflammatory drugs. Differential use in older patients.非甾体抗炎药。老年患者中的差异使用情况。
Drugs Aging. 1994 Feb;4(2):101-12. doi: 10.2165/00002512-199404020-00003.
3
Pharmacokinetic profile of controlled release ketoprofen in elderly patients.老年患者中缓释酮洛芬的药代动力学特征。
Br J Clin Pharmacol. 1985 Dec;20(6):567-73. doi: 10.1111/j.1365-2125.1985.tb05113.x.
4
The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.非甾体抗炎药在老年人中的药代动力学。
Clin Pharmacokinet. 1987 Feb;12(2):111-22. doi: 10.2165/00003088-198712020-00002.
5
Clinical pharmacokinetic considerations in the elderly. An update.老年人的临床药代动力学考量。最新进展。
Clin Pharmacokinet. 1989 Oct;17(4):236-63. doi: 10.2165/00003088-198917040-00003.
6
Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid.酮洛芬对映体在胆囊切除患者中的药代动力学：丙磺舒的影响。
Eur J Clin Pharmacol. 1989;37(6):589-94. doi: 10.1007/BF00562550.
7
Clinical pharmacokinetics of ketoprofen and its enantiomers.酮洛芬及其对映体的临床药代动力学。
Clin Pharmacokinet. 1990 Sep;19(3):197-217. doi: 10.2165/00003088-199019030-00004.
8
Pharmacokinetics and tolerance of romazarit after oral administration of ascending single doses to healthy human volunteers.健康人类志愿者口服递增单剂量罗美扎利后的药代动力学和耐受性。
Eur J Drug Metab Pharmacokinet. 1990 Oct-Dec;15(4):317-22. doi: 10.1007/BF03190221.
9
The problems and pitfalls of NSAID therapy in the elderly (Part II).老年人非甾体抗炎药治疗的问题与陷阱（第二部分）
Drugs Aging. 1991 May;1(3):212-27. doi: 10.2165/00002512-199101030-00005.
10
Clinical pharmacokinetics of ketorolac tromethamine.酮咯酸氨丁三醇的临床药代动力学。
Clin Pharmacokinet. 1992 Dec;23(6):415-27. doi: 10.2165/00003088-199223060-00003.
本文引用的文献
1
Probenecid-clofibrate interaction.
Clin Pharmacol Ther. 1981 Mar;29(3):351-8. doi: 10.1038/clpt.1981.48.
2
Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.尿液中酮洛芬、萘普生和丙磺舒原形药物的排泄量可忽略不计。
J Pharm Sci. 1980 Nov;69(11):1254-7. doi: 10.1002/jps.2600691105.
3
Pharmacokinetics of ketoprofen in patients with chronic renal failure.酮洛芬在慢性肾衰竭患者中的药代动力学。
Scand J Rheumatol. 1981;10(3):189-92. doi: 10.3109/03009748109095297.
4
Effects of probenecid on ketoprofen kinetics.
Clin Pharmacol Ther. 1982 Jun;31(6):705-12. doi: 10.1038/clpt.1982.99.
5
Pharmacokinetics of ketoprofen in the elderly.酮洛芬在老年人中的药代动力学。
Br J Clin Pharmacol. 1983 Jul;16(1):65-70. doi: 10.1111/j.1365-2125.1983.tb02145.x.
6
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.非甾体抗炎药的临床药代动力学
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
7
Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.肾衰竭患者中药物的葡萄糖醛酸化及葡萄糖醛酸苷的处置。综述。
Drug Metab Dispos. 1982 Jan-Feb;10(1):87-9.
8
Physiological disposition of fenoprofen in man. 3. Metabolism and protein binding of fenoprofen.非诺洛芬在人体中的生理处置。3. 非诺洛芬的代谢与蛋白结合
J Pharmacol Exp Ther. 1972 Nov;183(2):449-57.
9
Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy.
Clin Exp Pharmacol Physiol. 1979 May-Jun;6(3):267-73. doi: 10.1111/j.1440-1681.1979.tb01248.x.
10
Clofibrate disposition in renal failure and acute and chronic liver disease.氯贝丁酯在肾衰竭以及急慢性肝病中的处置情况。
Eur J Clin Pharmacol. 1979 Jun 12;15(5):341-7. doi: 10.1007/BF00558438.
Zotero 插件